Evidence map›Paper›PMID 33300297›Full record

ArticleBiotechnology progress2021

Transferability of miRNA-technology to bioprocessing: Influence of cultivation mode and media.

Ann-Cathrin Leroux, Elisabeth Bartels, Luise Winter, Melanie Mann, Kerstin Otte, Christoph Zehe

Open access · hybridAbstract read
In one paragraph

Article in Biotechnology progress, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ann-Cathrin LerouxProduct Development, Sartorius Stedim Cellca GmbH, Ulm, Germany.ORCID 0000-0002-1893-2848
Elisabeth BartelsProduct Development, Sartorius Stedim Cellca GmbH, Ulm, Germany.
Luise WinterProduct Development, Sartorius Stedim Cellca GmbH, Ulm, Germany.
Melanie MannProduct Development, Sartorius Stedim Cellca GmbH, Ulm, Germany.
Kerstin OtteBiology, Cell- and Molecular Biology, Biberach University of Applied Sciences, Biberach an der Riß, Germany.
Christoph ZeheAdvanced Biotech Applications Corporate Research, Sartorius Stedim Cellca GmbH, Ulm, Germany.
Sartorius (Germany) · DERentschler Biopharma (Germany) · DEUniversity of Applied Sciences Biberach · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The biopharmaceutical industry strives for improvement of their production processes. In recent years, miRNAs have been shown to positively impact the production capacity of recombinant CHO cells, especially with regard to difficult to express proteins. Effective and reliable gene regulation of process relevant target genes by miRNAs is a prerequisite for integrating them into the toolbox of industrial cell engineering strategies. However, most studies rely on transient transfection of miRNA mimics; there is low standardization in evaluation of miRNA function and little knowledge on transferability of effects found during transient expression to stable expression during industry relevant fed-batch cultivation. In order to provide more insight into this topic, we used the pcDNA6.2 vector for stable miRNA overexpression during batch and fed-batch cultivation in CHO DG44 cells, optimized the vector, and compared the miRNA levels and effects with those achieved by transfection of miRNA mimics. We found that miR-1 downregulated TWF1 mRNA in different recombinant CHO DG44 clones in a dose-dependent manner during transient batch cultivation. Cells stably overexpressing miR-1 also showed a TWF1 mRNA downregulation when cultivated in batch mode using in-house medium 1. However, when the cells stably overexpressing miR-1 were cultivated in fed-batch mode using in-house medium 2. Consequently, a change of cultivation mode and medium seems to have an impact on target gene regulation by miRNA. Taken together, our findings highlight the importance to standardize miRNA evaluations and test miRNAs in the final application environment.

Indexed as

AnimalsCell EngineeringCHO CellsCricetinaeCricetulusCulture MediaMicrofilament ProteinsMicroRNAsPlasmidsProtein-Tyrosine KinasesRNA, MessengerTransfectionCulture MediaMicrofilament ProteinsMicroRNAsMIRN1 microRNA, humanProtein-Tyrosine KinasesRNA, MessengerTWF1 protein, humanbioprocessCHOmiRNA

Identifiers

PMID33300297
PMCPMC8244005
OpenAlexW3112275181

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.